Sort
85,873 grants matching “alzheimers”
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
$2,109,311Terry Goldberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · AG
The Impact of Alzheimerâs Disease and Related Dementias on Nursing Home Care and Quality for Persons with Serious Mental Illness
$2,109,150Donovan T Maust · University Of Michigan At Ann Arbor · RF1 · FY2023 · AG
Alzheimers Disease Patient Registry
$2,108,574Ronald C Petersen · Mayo Clinic Rochester · U01 · FY2016 · AG
Alzheimers Disease Patient Registry
$2,108,574Ronald C Petersen · Mayo Clinic Rochester · U01 · FY2017 · AG
Alzheimers Disease Patient Registry
$2,108,574Ronald C Petersen · Mayo Clinic Rochester · U01 · FY2018 · AG
Impact of Amyloid on the Aging Brain
$2,108,435Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2011 · AG
Preventing Deaths Among Older Americans with Alzheimerâs Disease and Other Related Dementias Exposed to Hurricanes
$2,107,715Susan Anne Bell · University Of Michigan At Ann Arbor · RF1 · FY2023 · AG
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,107,346Colin Masters · University Of Melbourne · R01 · FY2021 · AG
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory
$2,107,225Rima F Kaddurah-Daouk · Duke University · U01 · FY2025 · AG
Administrative Core
$2,107,183Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2025 · AG
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$2,106,657Nigel H. Greig · National Institute On Aging · ZIA · FY2022 · AG
PREVENTABLE Trial Implementation Phase
$2,106,576Karen P Alexander · Duke University · U19 · FY2025 · AG
Sleep-dependent synaptic homeostasis in Alzheimer's disease
$2,106,477Graham Hugh Diering · Univ Of North Carolina Chapel Hill · RF1 · FY2021 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies
$2,106,031David A Bennett · Rush University Medical Center · R01 · FY2016 · AG
Clinical Core
$2,105,743Paul A. Newhouse · Vanderbilt University Medical Center · P20 · FY2022 · AG
Novel Imaging Biomarkers of Lipid and Ketone Metabolism in Alzheimer's Disease
$2,105,574Ravinder Reddy · University Of Pennsylvania · RF1 · FY2024 · AG
Pre-Clinical Testing Core
$2,104,994Paul Richard Territo · Indiana University Indianapolis · U54 · FY2023 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,104,992Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Risk Factors, Pathology, and Clinical Expressions of AD
$2,104,828David A Bennett · Rush University Medical Center · R01 · FY2019 · AG
Alzheimer Disease Research Center
$2,104,821Helena Chang Chui · University Of Southern California · P50 · FY2014 · AG
Data Science Research
$2,104,136Mark W Craven · University Of Wisconsin-Madison · U54 · FY2015 · AI
Epigenetic Aging Biomarkers of Mild Cognitive Impairment, Alzheimer's Disease and Related Dementias, and Brain Aging
$2,103,684Aladdin Shadyab · University Of California, San Diego · RF1 · FY2021 · AG
Biological role and pharmacology of EXPERA family proteins and their effect onsterol homeostasis
$2,102,917Assaf Alon · Yale University · R35 · FY2025 · GM
A data resource for high resolutionneuropathological and omics analysisof Alzheimer's disease
$2,102,201Michael Hawrylycz · Allen Institute · U19 · FY2024 · AG
Genetic Architecture of Alzheimerâs disease Proteinopathies
$2,101,955M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG